Literature DB >> 23019082

Gender differences in penetrance and phenotype in hypokalemic periodic paralysis.

Qing Ke1, Benyan Luo, Ming Qi, Yue Du, Weiping Wu.   

Abstract

INTRODUCTION: Hypokalemic periodic paralysis (HypoPP) is an autosomal dominant skeletal muscle ion channelopathy. Sex hormones are natural ion channel regulators. Different sex hormones have different effects on ion channels. A comparison of the penetrance and phenotype between males and females with HypoPP mutations should aid in proving that sex hormones play different roles in HypoPP and also provide the basis for the development of therapies against HypoPP.
METHODS: We identified all mutation carriers in 4 HypoPP families using PCR sequencing techniques. All patients underwent clinical investigation.
RESULTS: There were 8 men and 7 women mutation carriers in the 4 families. Male carriers had 100% penetrance, but female penetrance was only 28.57%. The highest attack frequency was 50-150 times/year for the men, whereas it was 30-50 times/year for the women. The attacks disappeared during pregnancy.
CONCLUSIONS: The penetrance and attack frequency were lower in women than in men with HypoPP mutations.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23019082     DOI: 10.1002/mus.23460

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  10 in total

Review 1.  Where genotype is not predictive of phenotype: towards an understanding of the molecular basis of reduced penetrance in human inherited disease.

Authors:  David N Cooper; Michael Krawczak; Constantin Polychronakos; Chris Tyler-Smith; Hildegard Kehrer-Sawatzki
Journal:  Hum Genet       Date:  2013-07-03       Impact factor: 4.132

2.  Mutations associated with hypokalemic periodic paralysis: from hotspot regions to complete analysis of CACNA1S and SCN4A genes.

Authors:  Raffaella Brugnoni; Eleonora Canioni; Massimiliano Filosto; Antonella Pini; Paola Tonin; Tommaso Rossi; Carlotta Canavese; Marica Eoli; Gabriele Siciliano; Giuseppe Lauria; Renato Mantegazza; Lorenzo Maggi
Journal:  Neurogenetics       Date:  2021-10-05       Impact factor: 2.660

3.  PharmGKB summary: very important pharmacogene information for CACNA1S.

Authors:  Katrin Sangkuhl; Robert T Dirksen; Maria L Alvarellos; Russ B Altman; Teri E Klein
Journal:  Pharmacogenet Genomics       Date:  2020-02       Impact factor: 2.000

4.  Novel mutations in human and mouse SCN4A implicate AMPK in myotonia and periodic paralysis.

Authors:  Silvia Corrochano; Roope Männikkö; Peter I Joyce; Philip McGoldrick; Jessica Wettstein; Glenda Lassi; Dipa L Raja Rayan; Gonzalo Blanco; Colin Quinn; Andrianos Liavas; Arimantas Lionikas; Neta Amior; James Dick; Estelle G Healy; Michelle Stewart; Sarah Carter; Marie Hutchinson; Liz Bentley; Pietro Fratta; Andrea Cortese; Roger Cox; Steve D M Brown; Valter Tucci; Henning Wackerhage; Anthony A Amato; Linda Greensmith; Martin Koltzenburg; Michael G Hanna; Abraham Acevedo-Arozena
Journal:  Brain       Date:  2014-10-27       Impact factor: 13.501

5.  The clinical and genetic heterogeneity analysis of five families with primary periodic paralysis.

Authors:  Quanquan Wang; Zhe Zhao; Hongrui Shen; Qi Bing; Nan Li; Jing Hu
Journal:  Channels (Austin)       Date:  2021-12       Impact factor: 2.581

6.  Ageing contributes to phenotype transition in a mouse model of periodic paralysis.

Authors:  Karen J Suetterlin; S Veronica Tan; Roope Mannikko; Rahul Phadke; Michael Orford; Simon Eaton; Avan A Sayer; Miranda D Grounds; Emma Matthews; Linda Greensmith; Michael G Hanna
Journal:  JCSM Rapid Commun       Date:  2021-05-05

7.  Expanding genotype/phenotype of neuromuscular diseases by comprehensive target capture/NGS.

Authors:  Xia Tian; Wen-Chen Liang; Yanming Feng; Jing Wang; Victor Wei Zhang; Chih-Hung Chou; Hsien-Da Huang; Ching Wan Lam; Ya-Yun Hsu; Thy-Sheng Lin; Wan-Tzu Chen; Lee-Jun Wong; Yuh-Jyh Jong
Journal:  Neurol Genet       Date:  2015-08-13

Review 8.  Physiological and Pathophysiological Insights of Nav1.4 and Nav1.5 Comparison.

Authors:  Gildas Loussouarn; Damien Sternberg; Sophie Nicole; Céline Marionneau; Francoise Le Bouffant; Gilles Toumaniantz; Julien Barc; Olfat A Malak; Véronique Fressart; Yann Péréon; Isabelle Baró; Flavien Charpentier
Journal:  Front Pharmacol       Date:  2016-01-14       Impact factor: 5.810

9.  Gender as a Modifying Factor Influencing Myotonic Dystrophy Type 1 Phenotype Severity and Mortality: A Nationwide Multiple Databases Cross-Sectional Observational Study.

Authors:  Celine Dogan; Marie De Antonio; Dalil Hamroun; Hugo Varet; Marianne Fabbro; Felix Rougier; Khadija Amarof; Marie-Christine Arne Bes; Anne-Laure Bedat-Millet; Anthony Behin; Remi Bellance; Françoise Bouhour; Celia Boutte; François Boyer; Emmanuelle Campana-Salort; Françoise Chapon; Pascal Cintas; Claude Desnuelle; Romain Deschamps; Valerie Drouin-Garraud; Xavier Ferrer; Helene Gervais-Bernard; Karima Ghorab; Pascal Laforet; Armelle Magot; Laurent Magy; Dominique Menard; Marie-Christine Minot; Aleksandra Nadaj-Pakleza; Sybille Pellieux; Yann Pereon; Marguerite Preudhomme; Jean Pouget; Sabrina Sacconi; Guilhem Sole; Tanya Stojkovich; Vincent Tiffreau; Andoni Urtizberea; Christophe Vial; Fabien Zagnoli; Gilbert Caranhac; Claude Bourlier; Gerard Riviere; Alain Geille; Romain K Gherardi; Bruno Eymard; Jack Puymirat; Sandrine Katsahian; Guillaume Bassez
Journal:  PLoS One       Date:  2016-02-05       Impact factor: 3.240

10.  Co-existence of Congenital Adrenal Hyperplasia and Familial Hypokalemic Periodic Paralysis due to CYP21A2 and SCN4A Pathogenic Variants

Authors:  Tuğba Çetin; İhsan Turan
Journal:  J Clin Res Pediatr Endocrinol       Date:  2021-01-04
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.